A study for a 30 year old man who takes Xolair - from FDA reports


Summary

357 males aged 30 (±5) who take the same drug are studied. This is a personalized study for a 30 year old male patient who has Urticaria Chronic. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Aug, 01, 2017

357 males aged 30 (±5) who take Xolair are studied.


Number of reports submitted per year:

Xolair for a 30-year old man.

Information of the patient in this study:

  • Age: 30
  • Gender: male
  • Conditions: Urticaria Chronic
  • Drugs taken:
    • Xolair (omalizumab)

eHealthMe real world results:

Most common side effects over time

< 1 month:
  • dizziness
  • fatigue
  • cough
  • loss of consciousness
  • throat irritation
  • headache
  • anaphylaxis
  • breathing difficulty
  • muscle aches
  • joint pain
1 - 6 months:
  • itching
  • breathing difficulty
  • drug ineffective
  • chest pain
  • urticaria
  • wheezing
  • hypersensitivity
  • anaphylaxis
  • dry skin
  • hyperventilation
6 - 12 months:
  • oedema peripheral
  • joint pain
  • injection site rash
  • dyslipidaemia
  • swallowing difficulty
  • gastric ulcer
  • gastritis
  • musculoskeletal pain
  • gait disturbance
  • malaise
1 - 2 years:
  • drug ineffective
  • chest pain
  • weight increased
  • malaise
  • hypoventilation
  • nasopharyngitis
  • fatigue
  • weakness
  • oropharyngeal pain
  • productive cough
2 - 5 years:
  • itching
  • dizziness
  • hypersensitivity
5 - 10 years:
  • drug hypersensitivity
10+ years:
n/a
not specified:
  • breathing difficulty
  • nasopharyngitis
  • fatigue
  • headache
  • high blood pressure
  • cough
  • weight increased
  • heart rate increased
  • hypersensitivity
  • dizziness

Top conditions involved for these people *:

  • Hypersensitivity (10 people, 2.80%)
  • Urticaria (9 people, 2.52%)
  • Rhinitis (9 people, 2.52%)
  • Gastroesophageal Reflux Disease (5 people, 1.40%)
  • Allergic Rhinitis (5 people, 1.40%)

Top co-used drugs for these people *:

  • Singulair (74 people, 20.73%)
  • Symbicort (69 people, 19.33%)
  • Ventolin (33 people, 9.24%)
  • Spiriva (27 people, 7.56%)
  • Prednisone (26 people, 7.28%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

Related studies:

Can you answer these questions?

More questions for: Xolair, Urticaria chronic

You may be interested in these reviews

More reviews for: Xolair, Urticaria chronic